MedTrace Logo

Reducing Intrusive Memories in Refugees and Asylum Seekers With PTSD

NCT04394156 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2022-11-04

No results posted yet for this study

Summary

This research study is designed to investigate the use of a simple cognitive task for decreasing the number of intrusive memories of traumatic events experienced by refugees and asylum seekers with a diagnosis of Post-traumatic Stress Disorder (PTSD) currently living in the UK. The intervention includes a memory reminder cue, a 10-minute time gap and then around 20 minutes playing the mobile phone game Tetris, using mental rotation instructions. The study will have a multiple baseline case-series design (AB), with a randomised duration of baseline length up to three weeks. Thus, participants will complete a no-intervention phase of up to three weeks, followed by an intervention phase. Please see the intervention section for more details about the intervention sessions. Follow ups are conducted after each week to monitor the frequency of intrusive memories of trauma in a pen-and-paper diary. It is predicted that participants will report fewer intrusive memories after receiving the intervention than in the preceding baseline phase.

Conditions

  • Post Traumatic Stress Disorder
  • Stress Disorders, Post-Traumatic
  • Stress Disorders, Traumatic
  • Trauma, Psychological
  • Trauma and Stressor Related Disorders
  • Mental Disorder

Interventions

BEHAVIORAL

Brief cognitive intervention

See the information provided in the experimental arm description.

Sponsors & Collaborators

  • Central and North West London NHS Foundation Trust

    collaborator OTHER

  • Uppsala University

    collaborator OTHER

  • University of Surrey

    lead OTHER

Principal Investigators

  • Emily Greenfield · University of Surrey

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-07
Primary Completion
2021-04-06
Completion
2021-04-06

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04394156 on ClinicalTrials.gov